vs
Side-by-side financial comparison of Agape ATP Corp (ATPC) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $399.1K, roughly 964.1× Agape ATP Corp). P3 Health Partners Inc. runs the higher net margin — -19.6% vs -94.4%, a 74.8% gap on every dollar of revenue. On growth, Agape ATP Corp posted the faster year-over-year revenue change (10.9% vs 3.8%). Over the past eight quarters, Agape ATP Corp's revenue compounded faster (11.9% CAGR vs -0.5%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
ATPC vs PIII — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $399.1K | $384.8M |
| Net Profit | $-376.9K | $-75.5M |
| Gross Margin | 58.6% | — |
| Operating Margin | -325.2% | -40.0% |
| Net Margin | -94.4% | -19.6% |
| Revenue YoY | 10.9% | 3.8% |
| Net Profit YoY | 53.4% | -28.8% |
| EPS (diluted) | $-2.76 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $399.1K | $384.8M | ||
| Q3 25 | $370.6K | $345.3M | ||
| Q2 25 | $465.5K | $355.8M | ||
| Q1 25 | $289.0K | $373.2M | ||
| Q4 24 | $359.8K | $370.7M | ||
| Q3 24 | $331.3K | $362.1M | ||
| Q2 24 | $313.0K | $379.2M | ||
| Q1 24 | $318.6K | $388.5M |
| Q4 25 | $-376.9K | $-75.5M | ||
| Q3 25 | $-586.8K | $-31.6M | ||
| Q2 25 | $-617.1K | $-20.4M | ||
| Q1 25 | $-698.9K | $-20.5M | ||
| Q4 24 | $-808.4K | $-58.6M | ||
| Q3 24 | $-509.6K | $-46.5M | ||
| Q2 24 | $-442.7K | $-12.0M | ||
| Q1 24 | $-709.7K | $-18.7M |
| Q4 25 | 58.6% | — | ||
| Q3 25 | 64.5% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 54.1% | — | ||
| Q4 24 | 49.5% | — | ||
| Q3 24 | 55.6% | — | ||
| Q2 24 | 61.8% | — | ||
| Q1 24 | 63.8% | — |
| Q4 25 | -325.2% | -40.0% | ||
| Q3 25 | -162.3% | -12.8% | ||
| Q2 25 | -136.8% | -9.6% | ||
| Q1 25 | -249.2% | -10.2% | ||
| Q4 24 | -235.7% | -37.4% | ||
| Q3 24 | -165.4% | -29.5% | ||
| Q2 24 | -144.9% | -8.3% | ||
| Q1 24 | -227.1% | -11.3% |
| Q4 25 | -94.4% | -19.6% | ||
| Q3 25 | -158.3% | -9.1% | ||
| Q2 25 | -132.6% | -5.7% | ||
| Q1 25 | -241.8% | -5.5% | ||
| Q4 24 | -224.7% | -15.8% | ||
| Q3 24 | -153.8% | -12.8% | ||
| Q2 24 | -141.4% | -3.2% | ||
| Q1 24 | -222.7% | -4.8% |
| Q4 25 | $-2.76 | $-23.08 | ||
| Q3 25 | $-0.01 | $-9.67 | ||
| Q2 25 | $-0.01 | $-6.23 | ||
| Q1 25 | $-0.07 | $-6.28 | ||
| Q4 24 | $-31.31 | $-23.13 | ||
| Q3 24 | $-0.13 | $-15.70 | ||
| Q2 24 | $-0.12 | $-7.37 | ||
| Q1 24 | $-0.18 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $140.1K | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | $22.5M | $-155.2M |
| Total Assets | $24.6M | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $140.1K | $25.0M | ||
| Q3 25 | $133.7K | $37.7M | ||
| Q2 25 | $216.0K | $38.6M | ||
| Q1 25 | $578.8K | $40.1M | ||
| Q4 24 | $2.0M | $38.8M | ||
| Q3 24 | $2.7M | $63.0M | ||
| Q2 24 | $3.2M | $73.1M | ||
| Q1 24 | $3.6M | $27.3M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
| Q4 25 | $22.5M | $-155.2M | ||
| Q3 25 | $22.8M | $-18.7M | ||
| Q2 25 | $23.4M | $44.5M | ||
| Q1 25 | $24.0M | $63.3M | ||
| Q4 24 | $1.9M | $75.9M | ||
| Q3 24 | $2.7M | $120.5M | ||
| Q2 24 | $3.2M | $166.8M | ||
| Q1 24 | $3.7M | $146.6M |
| Q4 25 | $24.6M | $656.6M | ||
| Q3 25 | $24.4M | $683.6M | ||
| Q2 25 | $24.7M | $731.6M | ||
| Q1 25 | $25.2M | $783.9M | ||
| Q4 24 | $3.2M | $783.4M | ||
| Q3 24 | $4.0M | $833.3M | ||
| Q2 24 | $4.3M | $892.8M | ||
| Q1 24 | $4.8M | $855.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-208.3K | $-25.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-208.3K | $-25.7M | ||
| Q3 25 | $-256.7K | $-15.4M | ||
| Q2 25 | $-494.5K | $-16.6M | ||
| Q1 25 | $-1.5M | $-33.5M | ||
| Q4 24 | $-645.3K | $-57.2M | ||
| Q3 24 | $-424.9K | $-22.6M | ||
| Q2 24 | $-412.5K | $-10.2M | ||
| Q1 24 | $-1.2M | $-20.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATPC
Segment breakdown not available.
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
